ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway

G. Rajapaksa, F. Nikolos, I. Bado, R. Clarke, J. Gustafsson, C. Thomas

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Unfolded protein response (UPR) is an adaptive reaction that allows cancer cells to survive endoplasmic reticulum (EnR) stress that is often induced in the tumor microenvironment because of inadequate vascularization. Previous studies report an association between activation of the UPR and reduced sensitivity to antiestrogens and chemotherapeutics in estrogen receptor α (ERα)-positive and triple-negative breast cancers, respectively. ERα has been shown to regulate the expression of a key mediator of the EnR stress response, the X-box-binding protein-1 (XBP-1). Although network prediction models have associated ERβ with the EnR stress response, its role as regulator of the UPR has not been experimentally tested. Here, upregulation of wild-type ERβ (ERβ1) or treatment with ERβ agonists enhanced apoptosis in breast cancer cells in the presence of pharmacological inducers of EnR stress. Targeting the BCL-2 to the EnR of the ERβ1-expressing cells prevented the apoptosis induced by EnR stress but not by non-EnR stress apoptotic stimuli indicating that ERβ1 promotes EnR stress-regulated apoptosis. Downregulation of inositol-requiring kinase 1α (IRE1α) and decreased splicing of XBP-1 were associated with the decreased survival of the EnR-stressed ERβ1-expressing cells. ERβ1 was found to repress the IRE1 pathway of the UPR by inducing degradation of IRE1α. These results suggest that the ability of ERβ1 to target the UPR may offer alternative treatment strategies for breast cancer.

Original languageEnglish (US)
Pages (from-to)4130-4141
Number of pages12
JournalOncogene
Volume34
Issue number31
DOIs
StatePublished - Jul 30 2015
Externally publishedYes

Bibliographical note

Funding Information:
We thank C Koumenis for the Bcl-2 expression vector and Anders Strom for the ERβ2 expression lentivirus. We also thank Efrocini Cuko for technical assistance with confocal microscopy. This study was supported by grants from the Swedish Cancer Society, the Robert A Welch Foundation (E-0004), the Emerging Technology Fund of Texas under Agreement 300-9-1958 and the U54-CA149147.

Fingerprint Dive into the research topics of 'ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway'. Together they form a unique fingerprint.

Cite this